200 related articles for article (PubMed ID: 33569703)
1. Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study.
Raskovalova T; Jacob MC; Bulabois CE; Mariette C; Scheffen L; Park S; Labarère J
Ann Hematol; 2021 May; 100(5):1149-1158. PubMed ID: 33569703
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.
Raskovalova T; Berger MG; Jacob MC; Park S; Campos L; Aanei CM; Kasprzak J; Pereira B; Labarère J; Cesbron JY; Veyrat-Masson R
Haematologica; 2019 Dec; 104(12):2382-2390. PubMed ID: 31004030
[TBL] [Abstract][Full Text] [Related]
3. Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes.
Raskovalova T; Scheffen L; Jacob MC; Vettier C; Bulabois B; Szymanski G; Chevalier S; Gonnet N; Park S; Labarère J
PLoS One; 2022; 17(11):e0276095. PubMed ID: 36399441
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study.
Raskovalova T; Scheffen L; Jacob MC; Chevalier S; Tondeur S; Bulabois B; Meunier M; Szymanski G; Lefebvre C; Planta C; Dumestre-Perard C; Gonnet N; Garban F; Merle R; Park S; Labarère J
BMJ Open; 2022 Oct; 12(10):e065850. PubMed ID: 36207039
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
[TBL] [Abstract][Full Text] [Related]
7. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
[TBL] [Abstract][Full Text] [Related]
10. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study.
Truong F; Smith BR; Stachurski D; Cerny J; Medeiros LJ; Woda BA; Wang SA
Leuk Res; 2009 Aug; 33(8):1039-46. PubMed ID: 19232722
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
[TBL] [Abstract][Full Text] [Related]
12. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
13. Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.
Vikentiou M; Psarra K; Kapsimali V; Liapis K; Michael M; Tsionos K; Lianidou E; Papasteriades C
Leuk Lymphoma; 2009 Mar; 50(3):401-9. PubMed ID: 19294559
[TBL] [Abstract][Full Text] [Related]
14. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
16. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
[TBL] [Abstract][Full Text] [Related]
17. [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes].
Araseki K; Matsuda A; Tohyama K; Ishikawa T; Kawabata H; Miyazaki Y; Nakao S; Tomonaga M; Takaori-Kondo A; Kurokawa M; Omine M; Ozawa K
Rinsho Ketsueki; 2012 Jul; 53(7):691-7. PubMed ID: 22975771
[TBL] [Abstract][Full Text] [Related]
18. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
Wesa KM; Cunningham-Rundles S; Klimek VM; Vertosick E; Coleton MI; Yeung KS; Lin H; Nimer S; Cassileth BR
Cancer Immunol Immunother; 2015 Feb; 64(2):237-47. PubMed ID: 25351719
[TBL] [Abstract][Full Text] [Related]
19. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
